When patients are diagnosed with Hodgkin's lymphoma, their doctor develops a treatment plan. The type of treatment a patient will get depends on the stage of the disease, the patient's symptoms, the patient's age and general health, and other factors.1 Children may receive different types of therapy than adults, and even people that are the same age with the same stage of cancer may get different treatments. Talk to your doctor if you have any questions about your treatment.

Radiation therapy and chemotherapy are the most common treatments for advanced Hodgkin's lymphoma, although other types of treatments are being studied.2 Talk to your doctor if you would like more information about treatments that are being studied for advanced Hodgkin's lymphoma.

Information on Hodgkin's lymphoma is reproduced courtesy of the National Cancer Institute: www.nci.nih.gov.

Back To Top

References:

  1. National Cancer Institute. Treatments. In: What you need to know aboutTM: Hodgkin's Disease. Available at: www.cancer.gov/cancertopics/wyntk/hodgkins/page6. Accessed June 21, 2005.
  2. National Cancer Institute. Methods of treatment. In: What you need to know aboutTM: Hodgkin's Disease. Available at: www.cancer.gov/cancertopics/wyntk/hodgkins/page9. Accessed June 21, 2005.

Back To Top

Important Safety Information

WARNING
It is recommended that MATULANE be given only by or under the supervision of a physician experienced in the use of potent antineoplastic drugs. Adequate clinical and laboratory facilities should be available to patients for proper monitoring of treatment.

Matulane is contraindicated in patients with known hypersensitivity to the drug or inadequate marrow reserve as demonstrated by bone marrow aspiration. Due consideration of this possible state should be given to each patient who has leukopenia, thrombocytopenia, or anemia.

Matulane in combination therapy is a potent chemotherapeutic agent. Before prescribing Matulane, the sections in the Prescribing Information concerning usage in pregnancy, occurrence of secondary cancers, monitoring required in liver and kidney disease, hematologic effects, CNS effects, and potentiation associated with alcohol and MAO inhibitors should be carefully evaluated.

Please see full Prescribing Information for Matulane indications and usage, contraindications, and warnings including boxed WARNINGS, precautions, and adverse reactions.